Digital Interventions for Cancer Survivors
(REACH:SMART Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests digital tools to help adolescent and young adult survivors of childhood cancer resume regular check-ups. It compares different methods of delivering information, such as written details or simple digital messages (Stage 1 Low Touch Intervention and Stage 1 Written Information), to determine which method more effectively encourages follow-up appointments. Participants will share their experiences through surveys and possibly interviews, aiding researchers in understanding the best ways to support ongoing care. This trial suits individuals aged 15-29 who had cancer before age 22 and have not had a follow-up visit in over 15 months. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance follow-up care for future survivors.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on digital interventions for cancer follow-up care, so it's best to discuss your medications with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that low-touch methods, such as providing personalized information or tracking symptoms, are generally safe. These methods help manage health conditions without causing major side effects. Similarly, studies have examined high-touch methods, which involve more personal interaction, for their ability to increase patient involvement in healthcare. These methods have been well-received, with no major safety issues reported. Both approaches aim to help cancer survivors reconnect with their healthcare needs without introducing new health risks.12345
Why are researchers excited about this trial?
Researchers are excited about these digital interventions for cancer survivors because they offer a personalized and adaptive approach to post-treatment care. Unlike traditional methods that might involve fixed schedules and in-person visits, these interventions range from written information to low and high-touch digital tools, responding to each survivor's engagement and needs. This flexibility allows for enhanced accessibility and can be tailored to improve patient engagement, potentially leading to better health outcomes. By integrating digital solutions, the aim is to streamline support and make it more accessible for survivors, possibly transforming the way post-cancer care is delivered.
What evidence suggests that this trial's digital interventions could be effective for cancer survivors?
This trial will explore various digital interventions for cancer survivors. Research has shown that digital tools can benefit those who have survived cancer. Participants in this trial will be assigned to different intervention arms. Studies on low-contact methods, which involve minimal direct interaction, have shown promise in managing patient care and improving health outcomes. For example, one study found that when community health workers led the program, emergency care visits significantly decreased. Providing written information alone also benefits, as it has increased patient satisfaction and involvement in their care. More personalized methods, involving more direct contact, have effectively encouraged the use of preventive health services. Overall, these digital methods can help cancer survivors maintain their follow-up care, potentially leading to better long-term health.678910
Are You a Good Fit for This Trial?
This trial is for adolescent and young adult survivors of childhood cancer. Participants should be interested in re-engaging with long-term follow-up care for their health post-cancer treatment. Specific eligibility criteria are not provided, but typically include age range and past cancer treatment history.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Stage 1 Intervention
Participants receive either a low touch intervention (LTI) with reminder text messages and informational resources or written information (WI) for up to 4 weeks.
Stage 2 Intervention
Participants are re-randomized based on responsiveness to Stage 1. Responders receive either maintenance or a stepped-up condition, while non-responders receive a stepped-up condition, which may include expanded LTI or a high touch intervention (HTI).
Follow-up
Participants are monitored for re-engagement in care and self-management outcomes at 20 weeks (T3) and 36 weeks (T4).
What Are the Treatments Tested in This Trial?
Interventions
- Stage 1 Low Touch Intervention
- Stage 1 Written Information
- Stage 2 High Touch Intervention
- Stage 2 Low Touch Intervention
- Stage 2 Written Information
Find a Clinic Near You
Who Is Running the Clinical Trial?
Children's Hospital of Philadelphia
Lead Sponsor
University of Pennsylvania
Collaborator
National Cancer Institute (NCI)
Collaborator
Nationwide Children's Hospital
Collaborator